Browse
Submit Data
Databases
API
Help

Dataset Information

9 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-49685

ABSTRACT: Identification of Myt1 as a subunit of the neural cell type-specific LSD1 complex

OTHER RELATED OMICS DATASETS IN: PRJNA214707

PROVIDER: E-GEOD-49685 | ExpressionAtlas | 2015-07-17

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

Mus musculus

Project description:Identification of Myt1 as a subunit of the neural cell type-specific LSD1 complex

| PRJNA214707 | ENA

Cell-type specific sequencing of microRNAs from complex animal tissues

Project description:Cell-type specific sequencing of microRNAs from complex animal tissues

| PRJNA412780 | ENA

UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells [ChIP-seq]

Project description:In this study, we demonstrate that the UBN1 or UBN2 subunit is mainly responsible for specific recognition and direct binding of H3.3 by the HIRA complex, while the HIRA subunit can enhance the binding affinity of UBN1 toward H3.3, but Cabin1 subunit cannot. We also demonstrate that both Ala87 and Gly90 residues of H3.3 are required and sufficient for the specific recognition and binding by UBN1. ChIP-seq studies reveal that two independent HIRA complexes (UBN1-HIRA and UBN2-HIRA) can cooperatively deposit H3.3 to cis-regulatory regions, including active promoters and active enhancers in mouse embryonic stem (mES) cells. Importantly, disruption of histone chaperone activities of UBN1 and UBN2 by FID/AAA mutation results in the defect of H3.3 deposition at promoters of developmental genes involved in neural differentiation, and subsequently causes the failure of activation of these genes during neural differentiation of mES cells. Together, our results provide novel insights into the mechanism by which the HIRA complex specifically recognizes and deposits H3.3 at promoters and enhancers of developmental genes, which plays a critical role in neural differentiation of mES cells

2018-08-23 | GSE117034 | GEO

Systematic functional characterization of BAF mutations yields novel intra-complex synthetic lethalities [ChIP-Seq]

Project description:Aberrations in genes coding for subunits of the BAF chromatin remodeling complex are highly abundant in human cancers. Currently, it is not understood how these loss-of-function mutations contribute to cancer development and how they can be targeted therapeutically. The cancer type specific occurrence patterns of certain subunit mutations suggest subunit-specific effects on BAF complex function, possibly by the formation of aberrant residual complexes. Here, we systematically characterize the effects of individual subunit loss on complex composition, chromatin accessibility and gene expression in a panel of knock-out cell lines deficient for 22 targetable BAF subunits. We observe strong, specific and often discordant alterations dependent on the targeted subunit and show that these explain intra-complex co-dependencies, including the novel synthetic lethal interactions SMARCA4-ARID2, SMARCA4-ACTB and SMARCC1-SMARCC2. These data provide insights into the role of different BAF subcomplexes in genome-wide chromatin organization and suggest novel approaches to therapeutically target BAF mutant cancers.

2019-04-30 | GSE108387 | GEO

Systematic functional characterization of BAF mutations yields novel intra-complex synthetic lethalities [ATAC-Seq]

2019-04-30 | GSE108386 | GEO

BAF subunit switching regulates chromatin accessibility to control cell cycle exit in the developing mammalian cortex [ATAC-seq]

Project description:mSWI/SNF or BAF chromatin regulatory complexes are dosage-sensitive regulators of human neural development frequently mutated in autism and intellectual disability. Cell cycle exit and differentiation of neural stem/progenitor cells is accompanied by BAF subunit switching to generate neuron-specific nBAF complexes. We manipulated the timing of BAF subunit exchange in vivo and found that early loss of the npBAF subunit BAF53a stalls cell cycle exit to disrupt neurogenesis. Loss of BAF53a results in decreased chromatin accessibility at specific neural transcription factor binding sites, including the pioneer factors Sox2 and Ascl1, due to Polycomb accumulation. This results in repression of cell cycle genes, thereby blocking cell cycle progression and differentiation. Cell cycle block upon Baf53a deletion could be rescued by premature expression of the nBAF subunit BAF53b but not by other major drivers of proliferation or differentiation. Wnt, EGF, FGF, Sox2, myc or Pax6 all fail to maintain proliferation in the absence of BAF53a, highlighting a novel mechanism underlying neural progenitor cell cycle exit in the continued presence of extrinsic proliferative cues.

2021-01-18 | GSE164989 | GEO

Cell-type specific sequencing of microRNAs from complex animal tissues II

Project description:Cell-type specific sequencing of microRNAs from complex animal tissues II

| PRJNA412779 | ENA

Cell-type specific sequencing of microRNAs from complex animal tissues III

Project description:Cell-type specific sequencing of microRNAs from complex animal tissues III

| PRJNA412778 | ENA

Cell-type specific sequencing of microRNAs from complex animal tissues IV

Project description:Cell-type specific sequencing of microRNAs from complex animal tissues IV

| PRJNA412782 | ENA

Cell-type specific sequencing of microRNAs from complex animal tissues V

Project description:Cell-type specific sequencing of microRNAs from complex animal tissues V